Fengjuan Han - Search Results

Year	Number of Results
2010	1
2011	3
2014	4
2015	1
2016	2
2017	1
2020	2
2021	6
2022	5
2023	6
2024	3

1

Research progress on the mechanism of glycolysis in ovarian cancer.

Li C, Liu FY, Shen Y, Tian Y, Han FJ. Li C, et al. Front Immunol. 2023 Nov 28;14:1284853. doi: 10.3389/fimmu.2023.1284853. eCollection 2023. Front Immunol. 2023. PMID: 38090580 Free PMC article. Review.

2

Icariin as a potential anticancer agent: a review of its biological effects on various cancers.

Liu FY, Ding DN, Wang YR, Liu SX, Peng C, Shen F, Zhu XY, Li C, Tang LP, Han FJ. Liu FY, et al. Front Pharmacol. 2023 Jun 30;14:1216363. doi: 10.3389/fphar.2023.1216363. eCollection 2023. Front Pharmacol. 2023. PMID: 37456751 Free PMC article. Review.

3

The role of vaginal microecology in the cervical cancer.

Wei W, Xie LZ, Xia Q, Fu Y, Liu FY, Ding DN, Han FJ. Wei W, et al. J Obstet Gynaecol Res. 2022 Sep;48(9):2237-2254. doi: 10.1111/jog.15359. Epub 2022 Jul 11. J Obstet Gynaecol Res. 2022. PMID: 35815344 Review.

4

Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.

Wang Y, Xie L, Liu F, Ding D, Wei W, Han F. Wang Y, et al. Among authors: han f. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117299. doi: 10.1016/j.jep.2023.117299. Epub 2023 Oct 8. J Ethnopharmacol. 2024. PMID: 37816474 Review.

5

Insights into the Role of Oxidative Stress in Ovarian Cancer.

Ding DN, Xie LZ, Shen Y, Li J, Guo Y, Fu Y, Liu FY, Han FJ. Ding DN, et al. Oxid Med Cell Longev. 2021 Oct 7;2021:8388258. doi: 10.1155/2021/8388258. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34659640 Free PMC article. Review.

6

Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study.

Liu S, Ding D, Liu F, Guo Y, Xie L, Han FJ. Liu S, et al. J Ovarian Res. 2024 Jan 23;17(1):22. doi: 10.1186/s13048-023-01340-w. J Ovarian Res. 2024. PMID: 38263045 Free PMC article.

7

New light on treatment of cervical cancer: Chinese medicine monomers can be effective for cervical cancer by inhibiting the PI3K/Akt signaling pathway.

Liu F, Xu J, Yang R, Liu S, Hu S, Yan M, Han F. Liu F, et al. Among authors: han f. Biomed Pharmacother. 2023 Jan;157:114084. doi: 10.1016/j.biopha.2022.114084. Epub 2022 Dec 5. Biomed Pharmacother. 2023. PMID: 36481407 Free article. Review.

8

Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms.

Fu Y, Ding DN, Shen Y, Jia LY, Yan MY, Wei W, Song CH, Han FJ. Fu Y, et al. Evid Based Complement Alternat Med. 2022 Apr 1;2022:9053930. doi: 10.1155/2022/9053930. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35399635 Free PMC article. Review.

9

Complementary and Alternative Medicine for Dysmenorrhea Caused by Endometriosis: A Review of Utilization and Mechanism.

Guo Y, Liu FY, Shen Y, Xu JY, Xie LZ, Li SY, Ding DN, Zhang DQ, Han FJ. Guo Y, et al. Evid Based Complement Alternat Med. 2021 Jul 2;2021:6663602. doi: 10.1155/2021/6663602. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34306150 Free PMC article. Review.

10

Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review.

Li Y, Yan MY, Chen QC, Xie YY, Li CY, Han FJ. Li Y, et al. Evid Based Complement Alternat Med. 2022 Jun 23;2022:2574438. doi: 10.1155/2022/2574438. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35783509 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year